Ro 63-0563

Ro 63-0563
Nazivi
	Preferisani IUPAC naziv 4-amino-N-[2,6-bis(metilamino)piridin-4-il]benzensulfonamid
	Drugi nazivi 4-amino-N-(2,6 bis-metilamino-piridin-4-il)-benzen sulfonamid • Ro 63-0563 • Ro-63-0563 • Ro63-0563 • Ro 63-0563 • Ro-63-0563 • [3H]Ro 63-0563 • CHEMBL46071 • 202466-77-1 • GTPL275 • SCHEMBL679027 • GTPL3246 • BDBM50090524 • Ro630563 • AKOS040749344 • Ro-630563 • L000518 • Q27088598
Identifikacija
3D model (Jmol)	interaktivna slika;
PubChem C ID	5312144;
	SMILES CNC1=CC(=CC(=N1)NC)NS(=O)(=O)C2=CC=C(C=C2)N; ; ; ; ; ;
Svojstva
Hemijska formula	C13H17N5O2S
Molarna masa	307,37 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Ro 63-0563 je antagonist 5-HT6 receptora.^[3]

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Eric P M Prinssen; Francis C Colpaert; Wouter Koek (2002-10-25). „5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy”. Eur J Pharmacol. 453 (2-3): 217—21. doi:10.1016/s0014-2999(02)02430-5.